| Structure | Chemical Name | CAS | MF |
|
FMoc-N-Me-beta-Ala-OH
|
172965-84-3
|
C19H19NO4
|
|
5'-O-DMT-N2-phenylacetylguanosine
|
172965-92-3
|
C39H37N5O8
|
|
1-(2-Fluoro-4-nitrophenyl)piperidine, 97%
|
172967-04-3
|
C11H13FN2O2
|
|
2-Cyclopenten-1-one,3-(acetyloxy)-2-fluoro-(9CI)
|
172968-83-1
|
C7H7FO3
|
|
Cyclohexanone, 2,3-difluoro-2-methyl-, cis- (9CI)
|
172968-86-4
|
C7H10F2O
|
|
Cyclohexanone, 2,3-difluoro-3-methyl-, cis- (9CI)
|
172969-00-5
|
C7H10F2O
|
|
2-Furancarboxylic acid, 5-(1-hydroxyethyl)-, methyl ester (9CI)
|
172969-54-9
|
C8H10O4
|
|
1H-Benzimidazole,5-(1H-1,2,3-triazol-1-yl)-(9CI)
|
172972-44-0
|
C9H7N5
|
|
3-Quinolinecarboxylic acid, 7-chloro-6-fluoro-1,4-dihydro-4-oxo-8-sulfo-
|
172972-89-3
|
C10H5ClFNO6S
|
|
Benzenesulfonic acid, 1-Methylbutyl ester
|
172973-68-1
|
C11H16O3S
|
|
3,5-Dimethylphenylboronic acid
|
172975-69-8
|
C8H11BO2
|
|
2-METHYL-BIPHENYL-3-YLAMINE(WXC08862)
|
172975-98-3
|
C13H13N
|
|
4-[(2-CHLOROPHENYL)HYDROXYPHENYLMETHYL]-BENZOIC ACID
|
172976-68-0
|
C20H15ClO3
|
|
cis-1,3-Indandiol
|
172977-38-7
|
C9H10O2
|
|
4-(4-METHYL-1H-IMIDAZOL-2-YL)-BENZONITRILE
|
172980-19-7
|
C11H9N3
|
|
Cyclopentanecarboxylic acid, 2-ethylidene-, methyl ester, (E)- (9CI)
|
172981-48-5
|
C9H14O2
|
|
Cyclopentanecarboxylic acid, 2-ethylidene-, methyl ester, (Z)- (9CI)
|
172981-49-6
|
C9H14O2
|
|
Pyrimidine, 2-(1-piperazinylmethyl)- (9CI)
|
172981-86-1
|
C9H14N4
|
|
5H-Pyrrolo[3,2-d]pyrimidine,2,4-diethoxy-(9CI)
|
172982-65-9
|
C10H13N3O2
|
|
4H-Pyrrolo[3,2,1-de]pteridine,5,6-dihydro-4-methyl-(9CI)
|
172982-69-3
|
C9H10N4
|
|
4H-Pyrrolo[3,2,1-de]pteridine,5,6-dihydro-4,5-dimethyl-(9CI)
|
172982-70-6
|
C10H12N4
|
|
1H-Pyrrolo[3,2,1-de]pteridin-2(4H)-one,5,6-dihydro-4-methyl-(9CI)
|
172982-72-8
|
C9H10N4O
|
|
1H-Indole-2-carboxaldehyde,3-hydroxy-(9CI)
|
172984-51-9
|
C9H7NO2
|
|
Methanone, (1-amino-8,9-dihydro-5,8,8-trimethyl-6H-furo(2,3-b)pyrano(4 ,3-d)pyridin-2-yl)(4-chlorophenyl)-
|
172985-17-0
|
|
|
1-Pyrrolidinecarboxylic acid, 2-(chlorocarbonyl)-5-oxo-, methyl ester, (S)- (9CI)
|
172988-55-5
|
C7H8ClNO4
|
|
(S)-3-(4-(BENZYLOXY)PHENYL)-2-BUTYRAMIDOPROPANOIC ACID
|
172992-35-7
|
C20H23NO4
|
|
cis-9,10-Epoxyoctadecanamide
|
172995-07-2
|
|
|
Pyrrolo[1,2-a]pyrazine-1,3,4(2H)-trione, 2-methyl- (9CI)
|
172997-07-8
|
C8H6N2O3
|
|
((CYS31,NVA34)-NEUROPEPTIDE Y (27-36))2
|
172997-92-1
|
C116H186N36O28S2
|
|
BUFORIN II
|
172998-24-2
|
C106H184N40O26
|
|
1-Azabicyclo[3.1.0]hexane-2-carboxylicacid,ethylester,(2S-trans)-(9CI)
|
173006-11-6
|
C8H13NO2
|
|
Cyclohexanethiol,5-methyl-2-(1-methylethyl)-,(1S,2R,5S)-(9CI)
|
173006-99-0
|
C10H20S
|
|
1,3-Dioxolane-4-carboxamide,2,2-dimethyl-,(S)-(9CI)
|
173009-78-4
|
C6H11NO3
|
|
Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-phosphates (esters), chlorides, sodium salts
|
173010-79-2
|
|
|
Phosphonic acid, [[4-(3,4-dihydro-8-methoxy-3-methyl-4-oxo-2-quinazolinyl)phenyl]methyl]-, diethyl ester (9CI)
|
173018-76-3
|
C21H25N2O5P
|
|
Phosphonic acid, [[4-(3,4-dihydro-6,7,8-trimethoxy-3-methyl-4-oxo-2-quinazolinyl)phenyl]methyl]-, diethyl ester (9CI)
|
173018-79-6
|
C23H29N2O7P
|
|
N,3-dimethylbenzenesulfonamide
|
173020-15-0
|
C8H11NO2S
|
|
4-(4-TrifluoroMethoxyphenyl)phenol
|
173025-79-1
|
C13H9F3O2
|
|
1-(2-Bromophenyl)-1-methylethylamine
|
173026-23-8
|
C9H12BrN
|
|
6-Fluoro-5-(4-methylpiperazin-1-yl)benzo[1,2,5]oxadiazol-1-oxide
|
173029-85-1
|
|
|
2-Propanone, 1-(methoxy-NNO-azoxy)- (9CI)
|
173030-37-0
|
C4H8N2O3
|
|
1,2,5-Oxadiazole-3-carboximidicacid,4-cyano-,hydrazide,5-oxide(9CI)
|
173030-56-3
|
C4H4N6O2
|
|
Oxirane, 2-(3,3-dimethyl-1-butynyl)-3-ethenyl-, trans- (9CI)
|
173032-92-3
|
C10H14O
|
|
Oxirane, 2-(3,3-dimethyl-1-butynyl)-3-ethenyl-, cis- (9CI)
|
173032-93-4
|
C10H14O
|
|
[1-(1'(R)-ALPHA-METHYLBENZYL)-AZIRIDIN-2(R)-YL]-METHANOL
|
173034-70-3
|
C11H15NO
|
|
1,3-BIS(2,4,6-TRIMETHYLPHENYL)-IMIDAZOLIDINIUM-CHLORIDE
|
173035-10-4
|
C21H29ClN2
|
|
1,3-Dimesitylimidazolidin-2-ylidene
|
173035-11-5
|
C21H26N2
|
|
METHYL 4-BENZYL-2-PHENYLOXAZOLE-5-CARBOXYLATE
|
173037-37-1
|
C18H15NO3
|
|
3-Furancarboxamide, 2-acetyl- (9CI)
|
173038-72-7
|
C7H7NO3
|
|
5-Isoxazolecarboxaldehyde, 3-(2-hydroxyethoxy)- (9CI)
|
173038-75-0
|
C6H7NO4
|
|
PMPA(NAALADaseinhibitor)
|
173039-10-6
|
C6H11O7P
|
|
Methyl-4,5-dimethoxy-2-iodobenzoate
|
173043-61-3
|
C10H11IO4
|
|
7-(4'-methylphenacyl)-1H-pyrrolo(2,3-b)pyridinium bromide
|
173045-16-4
|
C16H15BrN2O
|
|
Sibirioside A
|
173046-19-0
|
C21H28O12
|
|
BDP 12
|
173047-75-1
|
C14H15N3O
|
|
1-(4-CHLORO-[1,2,5]THIADIAZOL-3-YL)-PIPERIDINE
|
173053-54-8
|
C7H10ClN3S
|
|
BOC-D-PHE(4-NHFMOC)-OH
|
173054-11-0
|
C29H30N2O6
|
|
Benzaldehyde, 3-amino-, O-methyloxime (9CI)
|
173058-83-8
|
C8H10N2O
|
|
2-METHYL-5-NITRO-BENZALDEHYDE OXIME
|
173058-88-3
|
C8H8N2O3
|
|
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[[2-methoxy-6-(1-methylethyl)phenoxy]acetyl]piperazinedihydrochloride
|
173059-17-1
|
C26H34ClN5O5
|
|
3,6-dibroMo-9-(2-ethylhexyl)-9H-carbazole
|
173063-52-0
|
C20H23Br2N
|
|
6,7,8-Trioxabicyclo[3.2.1]octane,1-fluoro-5-methyl-(9CI)
|
173063-79-1
|
C6H9FO3
|
|
4-Chloro-6-(4-methoxy-phenyl)-pyrimidine
|
173064-29-4
|
C11H9ClN2O
|
|
5H-Cyclopenta[b]pyridin-5-one,6,7-dihydro-4-methyl-(9CI)
|
173064-87-4
|
C9H9NO
|
|
5H-Cyclopenta[b]pyridin-5-one,6,7-dihydro-2-methyl-(9CI)
|
173064-91-0
|
C9H9NO
|
|
(S)-2,2-Dimethyl-3-(N-Boc)-4-ethynyl-oxazolidine
|
173065-16-2
|
C12H19NO3
|
|
Carbamic acid, (1-methylene-2-propynyl)-, 1,1-dimethylethyl ester (9CI)
|
173065-18-4
|
C9H13NO2
|
|
6-(2-Nitrophenyl)-nicotinic acid ethyl ester
|
173065-29-7
|
C14H12N2O4
|
|
Benzoic acid, 4-[3-(acetyloxy)-2-methylpropyl]-, methyl ester, (R)- (9CI)
|
173065-76-4
|
C14H18O4
|
|
3-ETHYNYLFLUORANTHENE
|
173066-87-0
|
|
|
Ethanone, 2-chloro-2,2-difluoro-1-(4-methoxyphenyl)- (9CI)
|
173067-08-8
|
C9H7ClF2O2
|
|
5-Pyrimidinemethanol, -alpha--(1-methylethyl)-, (-alpha-S)- (9CI)
|
173068-90-1
|
C8H12N2O
|
|
5-Pyrimidinemethanol, -alpha--(1-methylethyl)-, (-alpha-R)- (9CI)
|
173068-91-2
|
C8H12N2O
|
|
2,2'-[(2,5-DIIODO-1,4-PHENYLENE)BIS(OXY-2,1-ETHANEDIYLOXY)]BIS[ETHANOL]
|
173068-97-8
|
C12H10I2O5
|
|
3-Pyridinethiol, 4-aMino-, (Hydrochloride) (1:1)
|
173069-45-9
|
C5H7ClN2S
|
|
Propanoic acid, 2-methyl-2-(2-methylhydrazino)- (9CI)
|
173072-45-2
|
C5H12N2O2
|
|
Benzoic acid, 4-[2-[(methylamino)carbonyl]hydrazino]- (9CI)
|
173072-46-3
|
C9H11N3O3
|
|
2-(5-TETRADECENYL)CYCLOBUTANONE
|
173074-85-6
|
C18H32O
|
|
GANODERIC ACID DM
|
173075-45-1
|
C30H44O4
|
|
Propanoic acid, 2,2-dimethyl-, (1S,3S,5Z,7R,8E,13E,15S,17R,21R,23R,25S)-1,21-dihydroxy-17-(1R)-1-hydroxyethyl-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo21.3.1.13,7.111,15nonacosa-8,11-dien-25-yl ester
|
173075-49-5
|
C42H62O14
|
|
Bicyclo[3.3.1]non-2-en-9-one, 8-ethoxy-5-ethyl- (9CI)
|
173083-87-9
|
C13H20O2
|
|
Ethanone, 1-(2-hydroxy-3-furanyl)- (9CI)
|
173083-90-4
|
C6H6O3
|
|
2-bromomethyl-5-thiazolecarboxylic acid ethyl ester
|
173089-24-2
|
C7H8BrNO2S
|
|
6-QUINOLINYL TRIFLUOROMETHANESULFONATE
|
173089-80-0
|
C10H6F3NO3S
|
|
6-Isoquinolinecarboxaldehyde (9CI)
|
173089-81-1
|
C10H7NO
|
|
METHYL ISOQUINOLINE-6-CARBOXYLATE
|
173089-82-2
|
C11H9NO2
|
|
methyl (2R)-2-[(5S)-5-[(5S)-5-benzyl-5-[(2S,3S)-2-hydroxy-3-[[(3S)-oxo lan-3-yl]oxycarbonylamino]-4-phenyl-butyl]-4-oxo-1H-pyrrol-3-yl]-5-(2- methylpropyl)-4-oxo-1H-pyrrol-3-yl]-3-phenyl-propanoate
|
173091-94-6
|
C44H51N3O8
|
|
[(3S)-oxolan-3-yl] N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2S)-2-(2-methylprop yl)-3-oxo-4-[(1R)-2-phenyl-1-(tert-butylcarbamoyl)ethyl]-1H-pyrrol-2-y l]-3-oxo-1H-pyrrol-2-yl]-3-hydroxy-1-phenyl-butan-2-yl]carbamate
|
173091-97-9
|
C47H58N4O7
|
|
11-Oxo-11H-pyrido[2,1-b]quinazoline-6-carbonitrile
|
173092-28-9
|
C13H7N3O
|
|
L-Altritol, 2,5-bis[[2-(acetylamino)benzoyl]amino]-1,2,5,6-tetradeoxy- 1,6-diphenyl-
|
173094-16-1
|
|
|
N-[(2S,3S,4R,5S)-3,4-dihydroxy-5-[[2-[(2-hydroxyacetyl)amino]benzoyl]a mino]-1,6-diphenyl-hexan-2-yl]-2-[(2-hydroxyacetyl)amino]benzamide
|
173094-23-0
|
C36H38N4O8
|
|
octakis(6-chloro-6-deoxy)-γ-cyclodextrin
|
173094-60-5
|
C48H72Cl8O32
|
|
2-(1H-indazol-5-ylamino)-nicotinic acid
|
173094-98-9
|
C13H10N4O2
|
|
2-(3,4-dimethoxy-phenylamino)-nicotinic acid
|
173095-00-6
|
C14H14N2O4
|
|
2-(2,3-dihydro-1,4-benzodioxin-6-yl)aminonicotinic acid
|
173095-01-7
|
C14H12N2O4
|
|
Isoguanosine Triacetate
|
173098-06-1
|
C16H19N5O8
|
|
10-Deacetyl Paclitaxel Propyl Analogue
|
173101-47-8
|
C42H51NO13
|
|
Iso CephaloMannine
|
173101-54-7
|
C45H53NO14
|
|
BUTYL ANALOG OF TAXOL, n-(RG)
|
173101-55-8
|
C45H55NO14
|
|
NITINE(BENZYL ANALOG OF TAXOL)(P)
|
173101-56-9
|
C48H53NO14
|